Evotec SE (EVO) Return on Capital Employed (2009 - 2025)
Evotec SE (EVO) reported Return on Capital Employed of 5.11% for Q4 2025, down 511.0% on a YoY basis from 1.24% in Q4 2024, and up 27.12% sequentially from 7.02% in Q3 2025.
Evotec SE (EVO) Return on Capital Employed (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 6 years of Return on Capital Employed data on file, last reported at 5.11% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed fell 511.0% year-over-year to 5.11%; the trailing twelve-month figure through Dec 2025 stood at 5.11% (down 511.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
- Return on Capital Employed grew to 5.11% in Q4 2025, from 7.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.0% in Q4 2021 to a low of 7.02% in Q3 2025.
- A 4-year average of 2.03% and a median of 0.01% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed slipped 2 bps in 2022 and tumbled 511 bps in 2025, its largest moves.
- Tracing EVO's Return on Capital Employed over 4 years: stood at 0.0% in 2021, then plunged by 174217 bps to 0.02% in 2022, then surged by 100 bps to 0.0% in 2024, then sank by 115270486 bps to 5.11% in 2025.
- Business Quant data shows EVO's Return on Capital Employed at 5.11% in Q4 2025, 7.02% in Q3 2025, and 0.0% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.11% |
| Sep 30, 2025 | -7.02% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2022 | -0.02% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2010 | -1,159.74% |
| Jun 30, 2010 | -2.05% |
| Mar 31, 2010 | 26,433,863.92% |
| Jun 30, 2009 | 13,757,199.92% |
| Mar 31, 2009 | 13,312,789.64% |